Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

被引:0
|
作者
Zagouri, F. [1 ]
Bamias, A. [5 ]
Papakostas, P. [2 ]
Karadimou, A. [1 ]
Bournakis, E. [1 ]
Dimopoulos, M. [1 ]
Fountzilas, G. [3 ]
Papadimitriou, C. A. [4 ]
机构
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
[2] Hippocrateio Hosp, Dept Med Oncol, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Thessaloniki, Greece
[4] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[5] Univ Athens, Sch Med, Dept Clin Therapeut 1, GR-11527 Athens, Greece
来源
BREAST | 2009年 / 18卷
关键词
D O I
10.1016/S0960-9776(09)70210-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S66 / S66
页数:1
相关论文
共 50 条
  • [1] Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group
    Papadimitriou, Christos A.
    Kalofonos, Haralambos
    Zagouri, Flora
    Papakostas, Pavlos
    Bozas, George
    Makatsoris, Thomas
    Dimopoulos, Meletios-A
    Fountzilas, George
    ONCOLOGY, 2009, 77 (3-4) : 212 - 216
  • [2] Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study
    Aravantinos, G
    Bafaloukos, D
    Dimopoulos, MA
    Nikolaides, C
    Papakostas, P
    Kiamouris, C
    Siklotis, K
    Rapsomaniki, T
    Fountzilas, G
    Skarlos, DV
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S238 - S238
  • [3] Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
    Fountzilas, G
    Christodoulou, C
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Aravantinos, G
    Razis, E
    Kalofonos, HP
    Papakostas, P
    Karina, M
    Gogas, H
    Skarlos, D
    CANCER INVESTIGATION, 2004, 22 (05) : 655 - 662
  • [4] Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase II study
    Fountzilas, G
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Christodoulou, C
    Timotheadou, E
    Kalofonos, C
    Kosmidis, P
    Adamou, A
    Papakostas, P
    Gogas, H
    Stathopoulos, G
    Razis, E
    Bafaloukos, D
    Skarlos, D
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1545 - 1551
  • [5] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
    Nicolaides, C
    Dimopoulos, MA
    Samantas, E
    Bafaloukos, D
    Kalofonos, C
    Fountzilas, G
    Razi, E
    Kosmidis, P
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 873 - 875
  • [6] Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
    Pectasides, D
    Aravantinos, G
    Kalofonos, H
    Kiamouris, C
    Bafaloukos, D
    Xiros, N
    Nicolaides, C
    Visvikis, A
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2001, 12 (10) : 1417 - 1422
  • [7] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Ford, Hugo E. R.
    Yap, Yoon-Sim
    Miles, David W.
    Makris, Andreas
    Hall, Marcia
    Miller, Liz
    Harries, Mark
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) : 809 - 815
  • [8] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [9] Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients - A Hellenic Cooperative Oncology Group Study
    Papadimitriou, CA
    Fountzilas, G
    Aravantinos, G
    Kalofonos, C
    Moulopoulos, LA
    Briassoulis, E
    Gika, D
    Dimopoulos, MA
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 152 - 159
  • [10] Weekly docetaxel in patients with pretreated metastatic breast cancer:: a phase II trial
    Mey, U
    Gorschlüt er, M
    Ziske, C
    Kleinschmidt, R
    Glasmacher, A
    Schmidt-Wolf, IGH
    ANTI-CANCER DRUGS, 2003, 14 (03) : 233 - 238